These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17579193)

  • 61. Long-term testosterone administration increases visceral fat in female to male transsexuals.
    Elbers JM; Asscheman H; Seidell JC; Megens JA; Gooren LJ
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2044-7. PubMed ID: 9215270
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mortality and morbidity in transsexual patients with cross-gender hormone treatment.
    Asscheman H; Gooren LJ; Eklund PL
    Metabolism; 1989 Sep; 38(9):869-73. PubMed ID: 2528051
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term safety of the oral androgen testosterone undecanoate.
    Gooren LJ
    Int J Androl; 1986 Feb; 9(1):21-6. PubMed ID: 2427455
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones.
    Mueller A; Gooren L
    Eur J Endocrinol; 2008 Sep; 159(3):197-202. PubMed ID: 18567667
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Voice problems in female-to-male transsexuals.
    Van Borsel J; De Cuypere G; Rubens R; Destaerke B
    Int J Lang Commun Disord; 2000; 35(3):427-42. PubMed ID: 10963024
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cross-sex hormone administration changes pain in transsexual women and men.
    Aloisi AM; Bachiocco V; Costantino A; Stefani R; Ceccarelli I; Bertaccini A; Meriggiola MC
    Pain; 2007 Nov; 132 Suppl 1():S60-S67. PubMed ID: 17379410
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Breast malignancy in female-to-male transsexuals: systematic review, case report, and recommendations for screening.
    Fledderus AC; Gout HA; Ogilvie AC; van Loenen DKG
    Breast; 2020 Oct; 53():92-100. PubMed ID: 32679529
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cross-Sex Hormones and Metabolic Parameters in Adolescents With Gender Dysphoria.
    Jarin J; Pine-Twaddell E; Trotman G; Stevens J; Conard LA; Tefera E; Gomez-Lobo V
    Pediatrics; 2017 May; 139(5):. PubMed ID: 28557738
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years.
    Madsen MC; van Dijk D; Wiepjes CM; Conemans EB; Thijs A; den Heijer M
    J Clin Endocrinol Metab; 2021 May; 106(6):1710-1717. PubMed ID: 33599731
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis.
    Tack LJ; Craen M; Dhondt K; Vanden Bossche H; Laridaen J; Cools M
    Biol Sex Differ; 2016; 7():14. PubMed ID: 26885361
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of testosterone administration on serum and urine kallikrein concentrations in female-to-male transsexuals.
    Slagter MH; Scorilas A; Gooren LJ; de Ronde W; Soosaipillai A; Giltay EJ; Paliouras M; Diamandis EP
    Clin Chem; 2006 Aug; 52(8):1546-51. PubMed ID: 16777918
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Endocrine intervention for transsexuals.
    Levy A; Crown A; Reid R
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):409-18. PubMed ID: 14510900
    [No Abstract]   [Full Text] [Related]  

  • 73. [Androgenic deficit and its treatment in stroke male patients with diabetes mellitus type II].
    Morgunov LIu; Denisova IA; Rozhkova TI; Stakhovskaia LV; Skvortsova VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 2):21-4. PubMed ID: 22224240
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hypertension as a complication of topical testosterone therapy.
    Tangredi JF; Buxton IL
    Ann Pharmacother; 2001 Oct; 35(10):1205-7. PubMed ID: 11675846
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Testosterone therapy for transgender men.
    Irwig MS
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):301-311. PubMed ID: 27084565
    [TBL] [Abstract][Full Text] [Related]  

  • 76. METABOLIC EFFECTS OF HORMONE THERAPY IN TRANSGENDER PATIENTS.
    Fernandez JD; Tannock LR
    Endocr Pract; 2016 Apr; 22(4):383-8. PubMed ID: 26574790
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Short-term safety profile of cross-hormonal therapy in trans-male subjects].
    Abdala R; Nagelberg A; Silveira F; Otero P; Mormandi E
    Medicina (B Aires); 2018; 78(6):399-402. PubMed ID: 30504106
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term hormonal therapy resulting in breast cancer in female-to-male transsexual: Case report.
    Treskova I; Hes O; Bursa V
    Medicine (Baltimore); 2018 Dec; 97(52):e13653. PubMed ID: 30593135
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of long-term administration of androgens on breast tissues of female-to-male transsexuals.
    Sapino A; Pietribiasi F; Godano A; Bussolati G
    Ann N Y Acad Sci; 1990; 586():143-5. PubMed ID: 2356995
    [No Abstract]   [Full Text] [Related]  

  • 80. Re: Safety of Physiological Testosterone Therapy in Women: Lessons From Female-to-Male Transsexuals (FMT) Treated With Pharmacological Testosterone Therapy.
    Seftel A
    J Urol; 2011 Apr; 185(4):1399. PubMed ID: 22098980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.